Corporate director convicted of insider trading [Investment Executive - News]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Investment Executive - News
A U.S. corporate director who traded on inside information about the planned acquisition of the company where he sat on the board has been convicted on securities fraud and insider trading charges. On Wednesday, a federal jury in New Jersey convicted four people — including the director who first learned about the proposed deal, Rouzbeh “Ross” Haghighat, and three others that he tipped off to the deal — of various charges in connection with an insider trading scheme that generated more than US$600,000 in illicit trading profits. According to court filings, in May 2023, Haghighat learned about the proposed acquisition of the Seattle-based biopharmaceutical company, Chinook Therapeutics, Inc., where has was a director, by Novartis AG, in a US$3.2-billion deal. In anticipation of that deal, he then bought securities in the company, and tipped three others, who also bought shares. And, in June 2023, the two companies negotiated a deal that caused the target company’s shares to spike, g
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador [Yahoo! Finance]Yahoo! Finance
- ???????????????????? : ???????????????2033????559????????????????????????(CAGR)6.25%??????? [CNET News]CNET News
- FDA commissioner unveils major reform to fast-track drug innovation [FOX Business Network]FOX Business Network
- Has Novartis' 24.5% Surge Left Further Upside After Strong Pipeline and Cash Flow Gains? [Yahoo! Finance]Yahoo! Finance
- Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website